China Sxt Pharmaceuticals (SXTC) revenue and earnings history
China Sxt Pharmaceuticals reported revenue of $1.14M for fiscal 2026 (year ended Mar 31, 2026), −34.6% on the year before, and net income of −$6.21M.
Over 9 years, from fiscal 2017 to fiscal 2026, revenue grew at a compound rate of −14.9% a year.
Revenue and net income, 10 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Mar 31, 2026 | $1.14M−34.6% | −$7.12M | −$6.21M | −$4.02M | — | — | $5.31M | — | — | $28.2M | $644K | 20-F |
| 2025ended Mar 31, 2025 |
The latest quarter, insider trades and fund moves: China Sxt Pharmaceuticals (SXTC) on OQRO.
Common questions
What was China Sxt Pharmaceuticals's revenue in fiscal 2026?
$1.14M for the year ended Mar 31, 2026, as reported in its 20-F filed Jul 1, 2026. That is −34.6% on fiscal 2025 ($1.74M).
How fast has China Sxt Pharmaceuticals's revenue grown?
From $4.88M in fiscal 2017 to $1.14M in fiscal 2026: a compound annual growth rate of −14.9% over 9 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has China Sxt Pharmaceuticals been profitable?
It reported a net loss in 7 of the years shown (2020, 2021, 2022, 2023, 2024, 2025, 2026). The highest net income was $1.54M in fiscal 2019.
Where these figures come from
The SEC’s companyfacts data: every figure China Sxt Pharmaceuticals tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.